Proteins in milk and blood could one day let doctors detect breast cancer earlier, and save lives

Doctors may someday be able to use bodily fluids to noninvasively detect breast cancer in patients earlier than is possible now.

Powered by WPeMatico

Ghostbots: AI versions of deceased loved ones could be a serious threat to mental health

We all experience loss and grief. Imagine, though, that you don’t need to say goodbye to your loved ones, that you can recreate them virtually so you can have conversations and find out how they’re feeling.

Powered by WPeMatico

Q&A: How meth became an epidemic in America, and what’s happening now that it’s faded from the headlines

Rural America has long suffered from an epidemic of methamphetamine use, which accounts for thousands of drug overdoses and deaths every year.

Powered by WPeMatico

Very low calorie diets safe for teens with obesity when monitored by a dietitian, say researchers

Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, says new research to be presented at the European Congress on Obesity (ECO 2024).

Powered by WPeMatico

Silchar psychiatrist booked for outraging modesty of women

Silchar: After a ‘Me Too’ movement stirred up on social media, a psychiatrist at Silchar Medical College and Hospital (SMCH) has been booked for allegedly sending objectionable and derogatory text messages to girls on social media.   

The city police registered an FIR against the doctor after complaints were filed about him texting demeaning, objectifying messages and making indecent proposals to young girls and women. The text messages were leaked on social media which caused controversy.   

In addition, complaints requiting the doctor’s suspension have been submitted to SMCH principal Dr Bhaskar Gupta on Tuesday and the Directorate of Medical Education, Assam (via email) on Wednesday.    

Also read- AIIMS Bilaspur Anaesthesiologist Removed On Allegations Of Sexually Assaulting Colleague

According to multiple media reports, the physiatrist messaged several women and also teenage girls from 17-year-old girls to those in their 30s and 40s. He was accused of making indecent proposals to them which outraged their modesty.  

The matter came to light when a girl from Silchar now residing in Bangalore came out on social media against the doctor with the mentioned allegations and with screenshots of his texts as evidence. The TOI reports that the girl’s post soon went viral on social media and many girls who also fell victim to the doctor’s alleged harassment shared screenshots, revealing that they had also received similar messages from him.   

According to the Barak bulletin news report, the victims also alleged that the doctor made remarks about the physical appearance of young women, treating them as objects and pressuring them into entering into intimate relationships with him, all without their consent. Those who did not comply were subjected to derogatory comments about their level of education.

The police action comes against the backdrop of the complaints made by two girls. Recording their statements and the evidence provided, the police registered a case against the doctor under relevant sections of Indian Penal Code (IPC). 

An investigation into the case is underway and the doctor has not yet responded to the allegations.   

Also read- Bengaluru Doctor Booked For Performing 74 Illegal Abortions In 3 Years

Powered by WPeMatico

Applications to NMC for New PG Medical Courses, Increase of Seats under Process, Clarifies GMC Jammu Principal amid Cancellation Rumours

Jammu: The National Medical Commission (NMC) has not rejected the applications for increase of postgraduate medical seats in Medicine and Paediatrics Departments at the Government Medical College (GMC) Jammu, but those applications are under progress as of March 15, 2024, informed the Principal of the Medical College.

This comes after sources informed Daily Excelsior that the Medical Assessment and Rating Board (MARB) of the Apex Medical Commission had cancelled the applications by GMC Jammu for starting the MD Biochemistry course and the increase of MD Medicine and MD Paediatrics seats.

Issuing clarifications on the increase of PG seats in Medicine and Paediatrics Department, the Principal of GMC Jammu, Dr. Ashutosh Gupta informed that the process of enhancement is under progress and there is no mention of any rejection of any kind anywhere.

Also Read: Admission beyond Sanctioned Capacity: NMC reduces 8 MBBS Seats at GMC Jammu for this academic year

Explaining that the process of enhancement of PG medical seats is done in five steps, Dr. Gupta told Daily Excelsior, “In first step, there is a scrutiny of applications at various levels and as per our knowledge more than one thousand PG seats enhancement applications including ours have been submitted by medical colleges across the country. After first scrutiny, only those colleges where the application are completed in all aspects are permitted and others are communicated in case of any shortcomings.”

“In the second step, the formal compliance is sought from medical colleges and in the third step after the institution submits the deficiencies, a review of deficiency/compliance is done by NMC followed by the fourth step wherein the final decision is taken by the NMC and the result is published,” he added.

He confirmed that as per the official information available with their office, their application is at stage 1 -it is under review as evident from the NMC portal. “NMC has no where mentioned in its website that application of GMC Jammu regarding enhancement of PG seats has been rejected,” he claimed. 

This clarification comes after the recent media report by the Daily claimed that the application for starting MD Biochemistry course and increase of seats in MD Medicine and MD Paediatrics got cancelled by NMC MARB.

Sources informed Daily Excelsior that GMC Jammu applied to start the MD Biochemistry course with 4 seats after surrendering 2 DNB seats for the year 2024-2025. Apart from this, the institute also applied for increase of 6 MD Medicine seats from existing 13 seats and increase of 6 MD seats in Paediatrics Department from existing 14 seats. However, unfortunately, all the three applications of GMC Jammu got rejected by NMC MARB.

“With this rejection, a loss in the form of Rs 16.5 lakh was also caused to the State exchequer as application fee per course was Rs 5.5 lakh and it was non-refundable in case of rejection of the application,” sources informed the Daily, adding that an inquiry should be ordered to ascertain the reason for rejection of all three applications.

They further demanded that it should come to light whether the applications submitted by the institute were incomplete or not in compliance with the NMC format or not in adherence with the NMC guidelines. “Accountability need to be fixed as it is big loss not only to the institution, state exchequer but also to the student community,” added the sources.

“Further, while applying for MD Biochemistry for the year 2024-2025, it is assumed that DNB course already operational in Department of Biochemistry must have been surrendered. In case it has been surrendered, then Department of Biochemistry in principal can not apply for the renewal of the courses for the academic year 2024-25, for which the last date is 31st of March but in case they have not declared the surrendering of the DNB courses while applying for MD course with NMC, then it amount to concealment of facts, which is academic offense and will be taken very seriously by the both regulatory authorities i.e. NBE and NMC,” the sources had told the Daily.

Medical Dialogues had earlier reported that MARB received a total of 1675 applications including 1010 applications for the start of PG courses and 665 applications for the increase of PG seats in existing medical colleges for the AY 2024-25. Among these, 1010 applications for starting PG medical courses and 665 applications for increasing PG medical seats in existing medical colleges, which the National Medical Commission (NMC) received, a total number of 10 institutes have withdrawn their applications.

Further, NMC sent communications to medical college in different phases in respect of 204 applications in the first lot, 214 applications in the second lot. Through a recent notice dated March 14, 2024, NMC issued clarifications regarding the communications sent to concerned applicant colleges and informed that the communications had been sent in respect of seeking deficient documents and information along with the submission of sworn affidavit.

Also Read: New PG medical courses or seat increase: NMC seeks submission of sworn affidavit, deficient documents, info from medical colleges

Powered by WPeMatico

Shortage of primary care doctors could bring crowded ERs: Study

Americans living in areas where primary care doctors and nurse practitioners are in short supply face a greater risk for emergency surgeries and complications, new research shows.

Powered by WPeMatico

Oman man gets new lease of life after heart transplant at MGM Hospital, Chennai

New Delhi: A patient from Oman got a new lease of life on Thursday after the family members of a deceased person from Shivpuri in Madhya Pradesh decided to donate his organs.

Rajesh (name changed), aged 48, who was initially on the list of hopeful kidney transplant recipients, tragically transitioned from being a potential recipient to becoming a donor after being declared brain-dead on March 14. Despite enduring years of anticipation for a suitable organ match, Rajesh’s journey took a poignant turn when his father, Ram Singh (name changed), aged 70, made the courageous decision to donate his kidney to save his son’s life.

Seeking a solution, he turned to a private hospital in Delhi where he consulted Dr. AK Bhalla, Chairman and Head of the Department of Nephrology, at Sir Ganga Ram Hospital, at a juncture where transplantation seemed the only option. With no other donor available, his 70-year-old father Ram Singh (name changed) decided to donate his kidney, fully aware of the risks associated with his age. He selflessly chose to undergo the transplant procedure to save his son’s life.

Also Read: After two failed kidney transplants, 41-year-old man undergoes transplant at Kauvery Hospital

Scheduled for surgery on March 8, their hopes were dashed when Rajesh suffered a severe brain stroke, leading to his untimely demise on March 13. However, amidst the heartbreak, Rajesh’s widow, Nalini, made the noble decision to honor her husband’s wishes and donate his organs.

“In accordance with his family’s wishes, arrangements were promptly made for Rajesh’s organs to be donated. Following assessments, his heart and liver were deemed suitable for donation. Given the narrow three-hour window for a heart transplant, the efficient Delhi Traffic Police swiftly organized a Green corridor from Sir Ganga Ram Hospital to the Indira Gandhi International Airport. Waiting at the airport tarmac was a chartered plane ready to transport Rajesh’s heart to MGM Hospital in Chennai,” Sir Ganga Ram Hospital informed in an official release, reports ANI.

The hospital stated further that a patient from Oman and their family were awaiting the life-saving transplant eagerly and this act forged a lasting bond between the families in Oman and Rajesh’s family here in India.

“There, a patient from Oman and their family awaited the life-saving transplant eagerly. The remarkable speed with which the Delhi Traffic Police facilitated this journey is truly commendable, ensuring that the heart transplant was successfully completed within the crucial three-hour timeframe. This act not only saved a life but also forged a lasting bond between the families in Oman and Rajesh’s family here in India, a connection unimaginable just days prior,” the statement further said.

“Rajesh’s liver found its recipient in a patient battling liver cirrhosis, registered since 2022. He had to undergo tapping every week. The liver transplant was done by Dr Ushast Dhir (Director, Department of Liver Transplant and Hepatobiliary Surgery Sir Ganga Ram Hospital). The courageous decision of the family, inspired by the story of Ms M (name changed), brought immense hope to two families amidst adversity,” the statement added.

Hailing it as a ‘noble act’, Dr Bhalla said, “It should motivate everyone to pledge their organs for donations after death. Please do not take your organs to heaven, we need them here!”

Also Read: MP: 64-year-old brain-dead patient gives new lease of life by donating liver

Powered by WPeMatico

CM Saha urges Tripura Medical College to establish Trauma Care Centre, Embrace CM-JAY Scheme

Agartala: In a bid to enhance healthcare services for the people of Tripura, Chief Minister Manik Saha urged Tripura Medical College and BRAM Teaching Hospital to establish a Trauma Care Centre and adopt the Chief Minister Jan Arogya Yojana (CM-JAY) during his visit on Wednesday.

CM Saha inaugurated eight new infrastructure facilities aimed at bolstering healthcare provisions in the region. The newly introduced amenities include a state-of-the-art ICU Complex in the new OPD building, modernized cabins, an open terrace with gardening facilities, and a new OT dedicated to the ENT Department. Additionally, initiatives such as the National Programme for Control of Blindness, a Retina Surgery Facility, the Skill Lab of Tripura College of Nursing, the Community Lab of Tripura College of Nursing, and a 30-bed high-end Dialysis Unit were inaugurated.

“The status of a hospital depends on the maintenance of emergency services. We are working on modernising the trauma centre. Health workers should not refer patients to other hospitals. We have opened Trauma Centres in 5 places, and people will benefit from that. Trauma centres are very important so TMC should also open a trauma centre,” the chief minister was quoted as saying in a release, reports ANI. 

“Due to financial issues, many people are unable to receive medical treatment. We have issued PM-Ayushman Bharat Yojana cards to 100 per cent, but 4.15 lakh households are left, so we have launched CM Jan Arogya Yojana. I want to tell the hospital authority to implement these schemes in TMC so that everyone will be covered under CM Jana Arogya Yojana. We have allocated around Rs 100 crores for this,” he said.

CM Saha reiterated the state government’s commitment to improving healthcare infrastructure and services, mentioning the opening of 100 sub-centres and the inauguration of a Cardiac Care Unit. He also emphasized the importance of telemedicine, emphasizing its potential to provide remote consultations and specialist opinions to patients, thereby reducing the need for travel outside the state for treatment.

Tripura Medical College Chairman Pramotesh Roy and Principal Arindam Datta, along with other dignitaries, were present at the event. The chief minister’s call for the establishment of a trauma care center and the implementation of CM-JAY reflects the government’s proactive approach towards ensuring accessible and quality healthcare services for all residents of Tripura.

Powered by WPeMatico

Bayer, Aignostics to collaborate on next generation precision oncology

Berlin: Bayer and Aignostics GmbH have announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin.

The partners will co-create a novel target identification platform that leverages Aignostics’ technology and proprietary multimodal patient cohorts, and Bayer’s deep expertise in discovering and developing novel oncology therapies. In addition, the collaboration will include the development of computational pathology algorithms powered by AI and machine learning (ML) that connect baseline pathology data, such as molecular tumor profiles, with clinical data, such as patient outcomes, to enable better patient identification, stratification, and selection for clinical trials.

The goal of the multi-year research collaboration is to identify novel cancer targets with a strong disease link through AI models applied to multimodal patient data and to accelerate clinical development of oncology programs. This approach has the potential to address some of the challenges currently experienced in target discovery and disease heterogeneity.

“Gaining insights into human disease biology, discovering targets with a strong disease link by integrating artificial intelligence, machine learning and multimodal pathology into precision drug development has a huge potential for our R&D innovation strategy. Bringing Aignostics’ technical knowhow and their access to large patient datasets together with Bayer’s expertise in cancer research and development will enable discoveries and faster clinical development, helping to provide cancer patients with more impactful medicines,” Christian Rommel, Member of the Executive Committee of Bayer’s Pharmaceuticals Division and Head of Research and Development said.

The collaboration will leverage Aignostics’ technology and access to longitudinal, multimodal clinical data sets in well characterized patient cohorts to discover new oncology targets for high unmet medical need indications. Under the terms of the agreement, the companies will collaborate on multiple discovery programs and initiate at least two target identification programs.

“Innovation at Aignostics has always been fueled by close collaboration with clinicians and biopharma. With this partnership, we’re thrilled to take that approach to the next level. Fusing our technology and multimodal data with Bayer’s extensive expertise in drug discovery and clinical development has the potential to generate better drugs for patients with high unmet need in less time. Together with Bayer, we’re excited to transform AI’s immense potential into a reality for healthcare,” said Viktor Matyas, CEO of Aignostics GmbH.

Aignostics will receive an upfront payment and is eligible to receive success-based milestone payments and royalties on any commercialized therapies that result from the collaboration.

 Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.

Read also: Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations

Powered by WPeMatico